Myo-InositolTrisPyroPhosphate Treatment Leads to HIF-1α Suppression and Eradication of Early Hepatoma Tumors in Rats

ChemBioChem

Volumn 12, Issue 5, 2011, Pages 777-783

  Aprahamian, Marc ^d   Bour, Gaétan ^d   Akladios, Chérif Y ^d   Fylaktakidou, Konstantina ^a,e   Greferath, Ruth ^a,b   Soler, Luc ^d   Marescaux, Jacques ^d   Egly, Jean Marc ^d   Lehn, Jean Marie ^a   Nicolau, Claude ^a,b,c  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b NormOxys Inc   (United States)

^c TUFTS UNIVERSITY   (United States)

^d IRCAD   (France)

^e DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; DOXORUBICIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INOSITOL TRISPHOSPHATE; MYOINOSITOL TRISPYROPHOSPHATE; OXYHEMOGLOBIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLOOD CELL COUNT; BLOOD OXYGEN TENSION; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENCY; ERYTHROCYTE; GENE EXPRESSION; HEMATOCRIT; HISTOLOGY; LIVER CELL CARCINOMA; MALE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OXYGEN DISSOCIATION CURVE; PRIORITY JOURNAL; RAT; RETICULOCYTE; THROMBOCYTE; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INOSITOL PHOSPHATES; LIVER; LIVER NEOPLASMS; MALE; OXYGEN; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; RATTUS;

EID: 79952653271     PISSN: 14394227     EISSN: 14397633     Source Type: Journal    
DOI: 10.1002/cbic.201000619     Document Type: Article

References (21)

1. B. P. Teisseire, C. Ropars, M. O. Vallez, B. P. Herigault, C. Nicolau, J. Appl. Physiol. 1985, 58, 1810-1817.
2. K. C. Fylaktakidou, J.-M. Lehn, R. Greferath, C. Nicolau, Bioorg. Med. Chem. Lett. 2005, 15, 1605-1608;
3. C. D. Duarte, R. Greferath, C. Nicolau, J.-M. Lehn, ChemBioChem 2010, 11, 2543-2548.
4. C. Kieda, R. Greferath, C. Crola da Silva, K. C. Fylaktakidou, J.-M. Lehn, C. Nicolau, Proc. Natl. Acad. Sci. USA 2006, 103, 15576-15581.
5. P. A. Farazi, R. A. DePinho, Nat. Rev. Cancer 2006, 6, 674-687.
6. G. L. Semenza, Science 2007, 318, 62-64.
7. M. Tomita, G. L. Semenza, C. Michiels, T. Matsuda, J.-N. Uchihara, T. Okudaira, Y. Tanaka, N. Taira, K. Ohshiro, N. Mori, Biochem. J. 2007, 406, 317-323;
8. R. Chowdhury, A. Hardy, C. J. Schofield, Chem. Soc. Rev. 2008, 37, 1308-1319.
9. G. Sihn, T. Walter, J.-C. Klein, I. Queguiner, H. Iwao, C. Nicolau, J.-M. Lehn, P. Corvol, J.-M. Gasc, FEBS Lett. 2007, 581, 962-966.
10. Q. Ke, M. Costa, Mol. Pharmacol. 2006, 70, 1469-1480.
11. M. E. Guicciardi, G. J. Gores, Gut. 2005, 54, 1024-1033.
12. H. P. Morris, B. P. Wagner, C. A. Velat, J. Natl. Cancer Inst. 1955, 16, 489-493.
13. H. P. Morris, B. P. Wagner, L. S. Lombard, J. Natl. Cancer Inst. 1958, 20, 1-35.
14. J. Trübenbach, F. Graepler, P. L. Pereira, P. Ruck, U. Lauer, M. Gregor, C.-D. Claussen, P. E. Huppert, Cardiovasc. Intervent. Radiol. 2000, 23, 211-217.
15. D. A. Bakan, J. K. Doerr-Stevens, J. P. Weichert, M. A. Longino, F. T. Lee, Jr., R. E. Counsell, Am. J. Ther. 2001, 8, 359-365.
16. L. Soler, H. Delingette, G. Malandain, J. Montagnat, N. Ayache, C. Koehl, O. Dourthe, B. Malassagne, M. Smith, D. Mutter, J. Marescaux, Comput. Aided. Surg. 2001, 6, 131-142.
17. L. Soler, C. Forest, S. Nicolau, C. Vayssiere, A. Wattiez, J. Marescaux, Eur Clinics. Obstet. Gynaecol. 2006, 2, 201-208.
18. First report of the BVA/FRAME/RSPCA/UFAW joint working group on refinement, Lab. Animals 1993, 27, 1-22.
19. O. Takahashi, Food Chem. Toxicol. 2000, 38, 203-218.